216 related articles for article (PubMed ID: 27766347)
1. ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial.
Murray AM; Hsu FC; Williamson JD; Bryan RN; Gerstein HC; Sullivan MD; Miller ME; Leng I; Lovato LL; Launer LJ;
Diabetologia; 2017 Jan; 60(1):69-80. PubMed ID: 27766347
[TBL] [Abstract][Full Text] [Related]
2. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.
Launer LJ; Miller ME; Williamson JD; Lazar RM; Gerstein HC; Murray AM; Sullivan M; Horowitz KR; Ding J; Marcovina S; Lovato LC; Lovato J; Margolis KL; O'Connor P; Lipkin EW; Hirsch J; Coker L; Maldjian J; Sunshine JL; Truwit C; Davatzikos C; Bryan RN;
Lancet Neurol; 2011 Nov; 10(11):969-77. PubMed ID: 21958949
[TBL] [Abstract][Full Text] [Related]
3. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial.
Williamson JD; Launer LJ; Bryan RN; Coker LH; Lazar RM; Gerstein HC; Murray AM; Sullivan MD; Horowitz KR; Ding J; Marcovina S; Lovato L; Lovato J; Margolis KL; Davatzikos C; Barzilay J; Ginsberg HN; Linz PE; Miller ME;
JAMA Intern Med; 2014 Mar; 174(3):324-33. PubMed ID: 24493100
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypoglycemia on brain structure in people with type 2 diabetes: epidemiological analysis of the ACCORD-MIND MRI trial.
Zhang Z; Lovato J; Battapady H; Davatzikos C; Gerstein HC; Ismail-Beigi F; Launer LJ; Murray A; Punthakee Z; Tirado AA; Williamson J; Bryan RN; Miller ME
Diabetes Care; 2014 Dec; 37(12):3279-85. PubMed ID: 25267796
[TBL] [Abstract][Full Text] [Related]
5. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Hugenschmidt CE; Lovato JF; Ambrosius WT; Bryan RN; Gerstein HC; Horowitz KR; Launer LJ; Lazar RM; Murray AM; Chew EY; Danis RP; Williamson JD; Miller ME; Ding J
Diabetes Care; 2014 Dec; 37(12):3244-52. PubMed ID: 25193529
[TBL] [Abstract][Full Text] [Related]
6. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.
Cukierman-Yaffe T; Bosch J; Diaz R; Dyal L; Hancu N; Hildebrandt P; Lanas F; Lewis BS; Marre M; Yale JF; Yusuf S; Gerstein HC;
Lancet Diabetes Endocrinol; 2014 Jul; 2(7):562-72. PubMed ID: 24898834
[TBL] [Abstract][Full Text] [Related]
7. Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial.
Cukierman-Yaffe T; Gerstein HC; Colhoun HM; Diaz R; García-Pérez LE; Lakshmanan M; Bethel A; Xavier D; Probstfield J; Riddle MC; Rydén L; Atisso CM; Hall S; Rao-Melacini P; Basile J; Cushman WC; Franek E; Keltai M; Lanas F; Leiter LA; Lopez-Jaramillo P; Pirags V; Pogosova N; Raubenheimer PJ; Shaw JE; Sheu WH; Temelkova-Kurktschiev T
Lancet Neurol; 2020 Jul; 19(7):582-590. PubMed ID: 32562683
[TBL] [Abstract][Full Text] [Related]
8. Obesity is associated with greater cognitive function in patients with type 2 diabetes mellitus.
Xing Z; Long C; Hu X; Chai X
Front Endocrinol (Lausanne); 2022; 13():953826. PubMed ID: 36353230
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
Mottl AK; Buse JB; Ismail-Beigi F; Sigal RJ; Pedley CF; Papademetriou V; Simmons DL; Katz L; Mychaleckyj JC; Craven TE
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1693-1702. PubMed ID: 30361335
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident CVD in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD-MIND Study.
Cukierman-Yaffe T; Gerstein HC; Miller ME; Launer LJ; Williamson JD; Horowitz KR; Ismail-Beigi F; Lazar RM
J Clin Endocrinol Metab; 2017 Sep; 102(9):3218-3225. PubMed ID: 28575229
[TBL] [Abstract][Full Text] [Related]
11. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial.
Sullivan MD; Katon WJ; Lovato LC; Miller ME; Murray AM; Horowitz KR; Bryan RN; Gerstein HC; Marcovina S; Akpunonu BE; Johnson J; Yale JF; Williamson J; Launer LJ
JAMA Psychiatry; 2013 Oct; 70(10):1041-7. PubMed ID: 23945905
[TBL] [Abstract][Full Text] [Related]
14. Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study.
Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Eye Study Group and the Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Study Group
Diabetes Care; 2016 Jul; 39(7):1089-100. PubMed ID: 27289122
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus.
Biessels GJ; Janssen J; van den Berg E; Zinman B; Espeland MA; Mattheus M; Johansen OE;
BMC Neurol; 2018 Jan; 18(1):7. PubMed ID: 29334906
[TBL] [Abstract][Full Text] [Related]
16. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.
Cukierman-Yaffe T; Gerstein HC; Williamson JD; Lazar RM; Lovato L; Miller ME; Coker LH; Murray A; Sullivan MD; Marcovina SM; Launer LJ;
Diabetes Care; 2009 Feb; 32(2):221-6. PubMed ID: 19171735
[TBL] [Abstract][Full Text] [Related]
17. The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods.
Williamson JD; Miller ME; Bryan RN; Lazar RM; Coker LH; Johnson J; Cukierman T; Horowitz KR; Murray A; Launer LJ;
Am J Cardiol; 2007 Jun; 99(12A):112i-122i. PubMed ID: 17599421
[TBL] [Abstract][Full Text] [Related]
18. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
Miller ME; Bonds DE; Gerstein HC; Seaquist ER; Bergenstal RM; Calles-Escandon J; Childress RD; Craven TE; Cuddihy RM; Dailey G; Feinglos MN; Ismail-Beigi F; Largay JF; O'Connor PJ; Paul T; Savage PJ; Schubart UK; Sood A; Genuth S;
BMJ; 2010 Jan; 340():b5444. PubMed ID: 20061360
[TBL] [Abstract][Full Text] [Related]
19. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
[TBL] [Abstract][Full Text] [Related]
20. Perioperative glycaemic control for people with diabetes undergoing surgery.
Bellon F; Solà I; Gimenez-Perez G; Hernández M; Metzendorf MI; Rubinat E; Mauricio D
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD007315. PubMed ID: 37526194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
